We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
SOLIFENACIN SANDOZ (Sandoz Pty Ltd)
Product name
SOLIFENACIN SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 working days (255)
Active ingredients
solifenacin succinate
Registration type
New generic medicine
Indication
SOLIFENACIN SANDOZ (tablet) is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.